| Name | Title | Contact Details |
|---|
Since the Company's inception in 1999, scientists and engineers at AutoGenomics have endeavored to create automated technologies that simplify the complex test processes inherent in genetic analysis within a format that is user friendly and increases productivity in the clinical laboratory. The INFINITI® system is designed specifically for processing AutoGenomics' unique proprietary BioFilmChip® microarrays that can be multiplexed and configured with hundreds of biomarkers to assess disease signatures from a single sample specimen. The INFINITI system provides clinical laboratories with significant improvements in laboratory productivity, workflow and cost per reportable result. Corporate Overview
Harnessing the power of the regulatory genome to create highly selective, next-generation molecular therapies
AOL is a global media and technology company, representing the best of all worlds: premium content and innovative technology. Our continued growth and evolution is the product of nearly a decade of careful cultivation of our internal strengths, coupled with thoughtful acquisitions and rigorous integration of the very best technologies and talents on the market. Today, AOL utilizes its four pillars of video, mobile, ad technology and platforms, and open ecosystems both within our own properties such as The Huffington Post, TechCrunch, Mapquest, and MAKERS as well as when working with brands to reach new audiences and drive compelling narratives in ways never done before.
FIGMD is a U.S.-based provider of healthcare quality measurement and improvement solutions.
Our extended workforce platform transforms how businesses engage, manage, and optimize external talent. We solve complexities of managing the modern workforce.